HLA-B18 as risk factor of liver fibrosis progression in HIV/HCV treatment-experienced patients

Pharmacogenomics J. 2017 Dec;17(6):479-480. doi: 10.1038/tpj.2016.80. Epub 2016 Oct 25.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Coinfection
  • Disease Progression
  • Genotype
  • HIV Infections / complications
  • HIV Infections / drug therapy*
  • HIV Infections / genetics
  • HLA-B18 Antigen / genetics*
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Hepatitis C / genetics
  • Humans
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / genetics*
  • Liver Cirrhosis / immunology
  • Risk Factors
  • Survival Analysis
  • Treatment Failure

Substances

  • HLA-B18 Antigen